NAT10 and hepatocellular carcinoma: Initial screening of NAT10 expression levels across seven commonly used HCC cell lines revealed significantly higher expression in SK‐HEP‐1 and HCCLM3 cells, as determined by WB and qPCR analyses (Figure S2A,B).